AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36214350 — intervention group
Group type: COMPARATOR
Intervention: Horizontal Implantation of the Implantable Collamer Lens (ICL)
Number of subjects: 46
Study 36214350 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Vertical and Horizontal Implantation of the ICL
Number of subjects: 46
Study 36214350 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical Implantation of the ICL
Number of subjects: 46
Study 34431170 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg once daily
Number of subjects: 1556
Study 34431170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1556
Study 32529467 — intervention group
Group type: EXPERIMENTAL
Intervention: Gossypol (20 mg once daily on days 1 to 14 every 21 days) combined with docetaxel (75 mg/m2) and cisplatin (75 mg/m2)
Number of subjects: 62
Study 32529467 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with docetaxel (75 mg/m2) and cisplatin (75 mg/m2)
Number of subjects: 62
Study 34479045 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (fruit and vegetable promotion activities for 7 months)
Number of subjects: 3414
Study 34479045 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual intervention: guided physical exercise 3 times/week)
Number of subjects: 3414
Study 33852934 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced mode of the patient programmer
Number of subjects: 30
Study 33852934 — intervention group
Group type: COMPARATOR
Intervention: Simple mode of the patient programmer
Number of subjects: 30
Study 32869364 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined potassium (39 K) and sodium (23 Na) MRI
Number of subjects: 10
Study 33080655 — intervention group
Group type: COMPARATOR
Intervention: Sham disbudding
Number of subjects: 337
Study 33080655 — intervention group
Group type: EXPERIMENTAL
Intervention: No anesthesia or pain medication
Number of subjects: 337
Study 33080655 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (sedation, local anesthesia, nonsteroidal antiinflammatory drugs)
Number of subjects: 337
Study 33080655 — intervention group
Group type: EXPERIMENTAL
Intervention: Disbudding at an older age
Number of subjects: 337
Study 33736863 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15% Triclosan
Number of subjects: 108
Study 33736863 — intervention group
Group type: EXPERIMENTAL
Intervention: Denture cleaning tablets
Number of subjects: 108
Study 33736863 — intervention group
Group type: EXPERIMENTAL
Intervention: Denture cleaning tablets plus gingival cleaning tablets
Number of subjects: 108
Study 33736863 — intervention group
Group type: COMPARATOR
Intervention: 0.25% sodium hypochlorite
Number of subjects: 108
Study 33736863 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.25% sodium hypochlorite)
Number of subjects: 108
Study 33278562 — intervention group
Group type: EXPERIMENTAL
Intervention: Females with anorexia nervosa (AN)
Number of subjects: 116
Study 33278562 — intervention group
Group type: COMPARATOR
Intervention: Control group (females without an eating disorder or menstrual dysfunction)
Number of subjects: 116
Study 33278562 — intervention group
Group type: EXPERIMENTAL
Intervention: Females with AN (elevated AMH)
Number of subjects: 116
Study 33278562 — intervention group
Group type: EXPERIMENTAL
Intervention: Females with AN (normal AMH)
Number of subjects: 116
Study 35144837 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA) 1 g IV
Number of subjects: 45
Study 35144837 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 45
Study 35144837 — intervention group
Group type: COMPARATOR
Intervention: No Intervention (NTXA)
Number of subjects: 45
Study 33757742 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed custom external nasal splint
Number of subjects: 40
Study 33757742 — intervention group
Group type: COMPARATOR
Intervention: Thermoplastic external nasal splint
Number of subjects: 40
Study 35771392 — intervention group
Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30 Global Health Status item
Number of subjects: 0
Study 35771392 — intervention group
Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30 and QLQ-LC13
Number of subjects: 0
Study 35771392 — intervention group
Group type: EXPERIMENTAL
Intervention: Various psychometric methods
Number of subjects: 0
Study 34024811 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 breaths per minute (BPM)
Number of subjects: 100
Study 34024811 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 breaths per minute (BPM)
Number of subjects: 100
Study 34024811 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 breaths per minute (BPM)
Number of subjects: 100
Study 34024811 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 to 8 breaths per minute (BPM)
Number of subjects: 100
Study 32676992 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence diagnostic model based on dynamic uncertain causality graph
Number of subjects: 202
Study 36011774 — intervention group
Group type: EXPERIMENTAL
Intervention: Part-time worker dissemination
Number of subjects: 3995
Study 36011774 — intervention group
Group type: EXPERIMENTAL
Intervention: Press release dissemination
Number of subjects: 3995
Study 36011774 — intervention group
Group type: EXPERIMENTAL
Intervention: Official communication from the Swiss Federal Office of Public Health
Number of subjects: 3995
Study 33232804 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (0.5 mg twice daily)
Number of subjects: 64
Study 33232804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 36099069 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin + Metformin (Saxa + Met)
Number of subjects: 648
Study 36099069 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin + Acarbose (Saxa + Aca)
Number of subjects: 648
Study 36099069 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin + Gliclazide (Saxa + Gli)
Number of subjects: 648
Study 34298547 — intervention group
Group type: EXPERIMENTAL
Intervention: A Healthy Start
Number of subjects: 364
Study 34298547 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 364
Study 32716358 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypharmacy (defined as taking five or more medications regularly)
Number of subjects: 514
Study 32716358 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of diabetes
Number of subjects: 514
Study 32716358 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of hyperlipidemia
Number of subjects: 514
Study 32716358 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of both diabetes and hyperlipidemia
Number of subjects: 514
Study 32716358 — intervention group
Group type: COMPARATOR
Intervention: Hypertension without diabetes or hyperlipidemia
Number of subjects: 514
Study 32496365 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow‐restricted resistance training (BFR‐RT) combined with aerobic training
Number of subjects: 24
Study 32496365 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training alone (control group)
Number of subjects: 24
Study 32496365 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow‐restricted resistance training (BFR‐RT)
Number of subjects: 24
Study 32503251 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D status (measured as 25(OH)D levels)
Number of subjects: 302
Study 34752723 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) gel pulpotomy
Number of subjects: 44
Study 34752723 — intervention group
Group type: COMPARATOR
Intervention: Formocresol (FC) pulpotomy
Number of subjects: 44
Study 34752723 — intervention group
Group type: COMPARATOR
Intervention: Ferric sulphate (FS) pulpotomy
Number of subjects: 44
Study 34098993 — intervention group
Group type: EXPERIMENTAL
Intervention: Chokeberry juice supplementation (200 ml per day for 7 weeks)
Number of subjects: 20
Study 34098993 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 20
Study 33969434 — intervention group
Group type: EXPERIMENTAL
Intervention: AT04A
Number of subjects: 72
Study 33969434 — intervention group
Group type: EXPERIMENTAL
Intervention: AT06A
Number of subjects: 72
Study 33969434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 33263744 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus 100 mg of aspirin once per day
Number of subjects: 0
Study 33263744 — intervention group
Group type: COMPARATOR
Intervention: 100 mg of aspirin once per day
Number of subjects: 0
Study 35751895 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydraulic maxillary sinus lift without bone grafting
Number of subjects: 68
Study 35751895 — intervention group
Group type: COMPARATOR
Intervention: Hydraulic maxillary sinus lift with bone grafting (Control)
Number of subjects: 68
Study 33298013 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline concordant Standard Care (gcSC) with adjunct exercise treatment for 12 weeks
Number of subjects: 120
Study 33298013 — intervention group
Group type: COMPARATOR
Intervention: Guideline concordant Standard Care (gcSC) alone
Number of subjects: 120
Study 33298013 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunct exercise treatment
Number of subjects: 120
Study 36011639 — intervention group
Group type: EXPERIMENTAL
Intervention: Safe sex education module based on Social Cognitive Theory (SCT)
Number of subjects: 0
Study 36011639 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment provided in Seremban health clinics
Number of subjects: 0
Study 33054794 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU/d vitamin D
Number of subjects: 84
Study 33054794 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/d vitamin D
Number of subjects: 84
Study 35960720 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 354
Study 35960720 — intervention group
Group type: COMPARATOR
Intervention: Standard care (including dexamethasone)
Number of subjects: 354
Study 35276716 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 40-80 mg/d
Number of subjects: 328
Study 35276716 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 120-160 mg/d
Number of subjects: 328
Study 35276716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328
Study 35276716 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 40-160 mg/d
Number of subjects: 328
Study 35961517 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of autologous skeletal muscle–derived cells
Number of subjects: 0
Study 35961517 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of autologous skeletal muscle–derived cells
Number of subjects: 0
Study 35961517 — intervention group
Group type: COMPARATOR
Intervention: Cell-free medium (Control)
Number of subjects: 0
Study 33949726 — intervention group
Group type: EXPERIMENTAL
Intervention: AVATAR therapy
Number of subjects: 25
Study 32447858 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve trunk stimulation therapy (Chize, Neiguan, Xiaohai)
Number of subjects: 42
Study 32447858 — intervention group
Group type: COMPARATOR
Intervention: Control group (acupuncture intervention)
Number of subjects: 42
Study 34407031 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drug
Number of subjects: 71
Study 34407031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 32440111 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized glycopyrrolate (GLY) 25 µg twice daily (BID)
Number of subjects: 861
Study 32440111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 861
Study 35952325 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 90
Study 35952325 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 90
Study 33521131 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep cervical flexor (DCF) muscle training using pressure biofeedback in addition to conventional exercises for neck pain.
Number of subjects: 65
Study 33521131 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercises only (Control group).
Number of subjects: 65
Study 32483072 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser‐assisted cataract surgery (FLACS)
Number of subjects: 96
Study 32483072 — intervention group
Group type: COMPARATOR
Intervention: Conventional phacoemulsification cataract surgery (CPS)
Number of subjects: 96
Study 35357281 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change interventions at Healthy Life Centres (HLCs)
Number of subjects: 118
Study 35357281 — intervention group
Group type: EXPERIMENTAL
Intervention: Short, additional healthy eating education programme
Number of subjects: 118
Study 35357281 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 118
Study 33721102 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe vitamin D deficiency
Number of subjects: 10
Study 32661292 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary Time (ST)
Number of subjects: 232
Study 32661292 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 232
Study 34173900 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibling opportunity to say goodbye
Number of subjects: 88
Study 34173900 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence at the death
Number of subjects: 88
Study 34173900 — intervention group
Group type: EXPERIMENTAL
Intervention: Wishing they had done something differently
Number of subjects: 88
Study 34173900 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother reports of sibling internalizing symptoms
Number of subjects: 88
Study 34528132 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mL water (HYP)
Number of subjects: 14
Study 34528132 — intervention group
Group type: COMPARATOR
Intervention: Volume of water equal to 90% of sweat losses (EU)
Number of subjects: 14
Study 33185325 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG-IFNα/TDF
Number of subjects: 120
Study 33185325 — intervention group
Group type: COMPARATOR
Intervention: PEG-IFNα/PBO
Number of subjects: 120
Study 36107497 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT)
Number of subjects: 30
Study 33892653 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.1 mg/kg intravenous bolus 10 hours before surgery)
Number of subjects: 116
Study 33892653 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 116
Study 32233940 — intervention group
Group type: EXPERIMENTAL
Intervention: guselkumab
Number of subjects: 0
Study 32233940 — intervention group
Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 0
Study 34939580 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentavac vaccine
Number of subjects: 900
Study 34939580 — intervention group
Group type: EXPERIMENTAL
Intervention: Shan 5 vaccine
Number of subjects: 900
Study 34939580 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentabio vaccine
Number of subjects: 900
Study 34939580 — intervention group
Group type: COMPARATOR
Intervention: Local adverse events
Number of subjects: 900
Study 34939580 — intervention group
Group type: COMPARATOR
Intervention: Systemic adverse events
Number of subjects: 900
Study 32285233 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding Our Peers with Pablo programme
Number of subjects: 222
Study 32285233 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 222
Study 35323106 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 26
Study 35323106 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric Strength Training (IST)
Number of subjects: 26
Study 35323106 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 26
Study 35323106 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (PT and IST)
Number of subjects: 26
Study 33626198 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Therapy & Exercises Group (MTEG)
Number of subjects: 17
Study 33626198 — intervention group
Group type: COMPARATOR
Intervention: Home Exercises Group (HEG)
Number of subjects: 17
Study 32492206 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 strain from Bangladesh
Number of subjects: 0
Study 35416908 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 171
Study 34563973 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Ketamine
Number of subjects: 30
Study 36004709 — intervention group
Group type: EXPERIMENTAL
Intervention: HD + P. ostreatus (1 kg of P. ostreatus per week, four portions of 250 g)
Number of subjects: 30
Study 36004709 — intervention group
Group type: COMPARATOR
Intervention: HD (healthy diet without edible mushrooms)
Number of subjects: 30
Study 32068241 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide
Number of subjects: 61
Study 32068241 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine-CR
Number of subjects: 61
Study 34774485 — intervention group
Group type: EXPERIMENTAL
Intervention: Friedewald-calculated LDL-C
Number of subjects: 6122
Study 34774485 — intervention group
Group type: EXPERIMENTAL
Intervention: Martin-Hopkins-calculated LDL-C
Number of subjects: 6122
Study 34774485 — intervention group
Group type: EXPERIMENTAL
Intervention: NIH equation 2-calculated LDL-C
Number of subjects: 6122
Study 34774485 — intervention group
Group type: EXPERIMENTAL
Intervention: NIH equation 2
Number of subjects: 6122
Study 34774485 — intervention group
Group type: EXPERIMENTAL
Intervention: All three methods (Friedewald, Martin-Hopkins, NIH equation 2)
Number of subjects: 6122
Study 32781440 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sleep hygiene recommendations and mindfulness intervention
Number of subjects: 17
Study 32781440 — intervention group
Group type: COMPARATOR
Intervention: Control (unassisted sleep during a tournament week)
Number of subjects: 17
Study 32781440 — intervention group
Group type: COMPARATOR
Intervention: Baseline (unassisted, habitual sleep during a regular training week)
Number of subjects: 17
Study 33945982 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine 200 mg IV three times daily for 7 days
Number of subjects: 64
Study 33945982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 32103358 — intervention group
Group type: EXPERIMENTAL
Intervention: BLESS program (12-week social capital-based exercise adherence program)
Number of subjects: 48
Study 32103358 — intervention group
Group type: COMPARATOR
Intervention: Control group (written information on exercise)
Number of subjects: 48
Study 32103358 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BLESS program and control)
Number of subjects: 48
Study 35593783 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 0
Study 35593783 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 0
Study 35593783 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab (both doses)
Number of subjects: 0
Study 32963063 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention targeting general practitioners (GPs) with a rapid referral service for quick insertion
Number of subjects: 0
Study 35016629 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality-based Motor Control Training (VRT)
Number of subjects: 30
Study 35016629 — intervention group
Group type: COMPARATOR
Intervention: Conventional Occupational Therapy (COT)
Number of subjects: 30
Study 32290266 — intervention group
Group type: EXPERIMENTAL
Intervention: SettleIN programme
Number of subjects: 19
Study 32290266 — intervention group
Group type: COMPARATOR
Intervention: Residential care as usual
Number of subjects: 19
Study 36371623 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based Comprehensive Cardiac Rehabilitation Therapy (TaCT) electronic cardiac rehabilitation (eCR) intervention
Number of subjects: 100
Study 36371623 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 33757774 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser therapy
Number of subjects: 30
Study 33757774 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 30
Study 33757774 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (Fractional CO2 laser and Sham)
Number of subjects: 30
Study 35567653 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacritinib
Number of subjects: 0
Study 35567653 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 33132345 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape Seed Extract (GSE)
Number of subjects: 20
Study 33132345 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 20
Study 36324127 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily test mouth rinse containing Cetylpyridinium chloride (CPC) and essential oils for 12 weeks
Number of subjects: 118
Study 36324127 — intervention group
Group type: COMPARATOR
Intervention: Carrier rinse control for 12 weeks
Number of subjects: 118
Study 34889785 — intervention group
Group type: EXPERIMENTAL
Intervention: Flap fixation method
Number of subjects: 105
Study 35482016 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaging (ultrasound followed by CT if necessary)
Number of subjects: 181
Study 35482016 — intervention group
Group type: COMPARATOR
Intervention: Observation (reassessed after 6-8 hours with repeated scoring)
Number of subjects: 181
Study 35482016 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaging
Number of subjects: 181
Study 35482016 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 181
Study 32699282 — intervention group
Group type: EXPERIMENTAL
Intervention: Burst-tree decomposition method
Number of subjects: 0
Study 32699282 — intervention group
Group type: EXPERIMENTAL
Intervention: Kernel-based model for generating event sequences
Number of subjects: 0
Study 36435542 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive restructuring plus imagery rescripting (CR + ImRs)
Number of subjects: 53
Study 36435542 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist attention placebo plus imagery rescripting (PLA + ImRs)
Number of subjects: 53
Study 36435542 — intervention group
Group type: COMPARATOR
Intervention: Double therapist attention placebo (PLA + PLA)
Number of subjects: 53
Study 36123102 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly absorbable oral curcumin (brand name: curcuRouge)
Number of subjects: 60